Rialto Wealth Management, LLC Bridge Bio Pharma, Inc. Transaction History
Rialto Wealth Management, LLC
- $303 Billion
- Q4 2024
A detailed history of Rialto Wealth Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Rialto Wealth Management, LLC holds 429 shares of BBIO stock, worth $13,663. This represents 0.0% of its overall portfolio holdings.
Number of Shares
429Holding current value
$13,663% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
298Shares Held
171MCall Options Held
10.4MPut Options Held
2.33M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$805 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$800 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$452 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$396 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$193 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.72B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...